Intellia Therapeutics (NTLA) FCF Margin Growth (1y) (2016 - 2026)
Intellia Therapeutics (NTLA) FCF Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Intellia Therapeutics | 1.32 Bn | 1.32 Bn | - | 11,639.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,639.00 |
| Dec 31, 2025 | 36,177.00 |
| Sep 30, 2025 | 36,308.00 |
| Jun 30, 2025 | 11,064.00 |
| Mar 31, 2025 | -47,053.00 |
| Dec 31, 2024 | -494,680.00 |
| Sep 30, 2024 | -4,680.00 |
| Jun 30, 2024 | -11,108.00 |
| Mar 31, 2024 | 46,956.00 |
| Dec 31, 2023 | 494,148.00 |
| Sep 30, 2023 | -30,143.00 |
| Jun 30, 2023 | -9,163.00 |
| Mar 31, 2023 | -15,295.00 |
| Dec 31, 2022 | -21,053.00 |
| Sep 30, 2022 | 38,548.00 |
| Jun 30, 2022 | 27,009.00 |
| Mar 31, 2022 | 8,435.00 |
| Dec 31, 2021 | 17,707.00 |
| Sep 30, 2021 | -83,654.00 |
| Jun 30, 2021 | -123,239.00 |